BOLT BIOTHERAPEUTICS INC's ticker is BOLT and the CUSIP is 097702104. A total of 62 filers reported holding BOLT BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,091,119 | -18.8% | 1,049,153 | 0.0% | 0.33% | +41.5% |
| Q2 2023 | $1,342,916 | -7.9% | 1,049,153 | 0.0% | 0.24% | -21.6% |
| Q1 2023 | $1,458,323 | +6.9% | 1,049,153 | 0.0% | 0.30% | +2.4% |
| Q4 2022 | $1,363,899 | -12.2% | 1,049,153 | 0.0% | 0.29% | -18.8% |
| Q3 2022 | $1,553,000 | -27.4% | 1,049,153 | 0.0% | 0.36% | -36.5% |
| Q2 2022 | $2,140,000 | -25.6% | 1,049,153 | 0.0% | 0.57% | -21.3% |
| Q1 2022 | $2,875,000 | -20.4% | 1,049,153 | +42.3% | 0.72% | +3.3% |
| Q4 2021 | $3,614,000 | -61.3% | 737,459 | 0.0% | 0.70% | -52.1% |
| Q3 2021 | $9,329,000 | -18.2% | 737,459 | 0.0% | 1.46% | +4.1% |
| Q2 2021 | $11,401,000 | -53.0% | 737,459 | 0.0% | 1.41% | -68.6% |
| Q1 2021 | $24,270,000 | – | 737,459 | – | 4.48% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hawkeye Capital Management, LLC | 415,039 | $431,641 | 1.06% |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1,213,630 | 0.98% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $1,967,126 | 0.78% |
| TANG CAPITAL MANAGEMENT LLC | 3,557,040 | $3,699,322 | 0.52% |
| Vivo Capital, LLC | 3,871,291 | $4,026,143 | 0.44% |
| Samsara BioCapital, LLC | 1,049,153 | $1,091,119 | 0.33% |
| Acuitas Investments, LLC | 460,379 | $478,794 | 0.28% |
| Newtyn Management, LLC | 1,020,000 | $1,060,800 | 0.26% |
| Sofinnova Investments, Inc. | 2,754,437 | $2,864,614 | 0.18% |
| Privium Fund Management (UK) Ltd | 116,516 | $121,177 | 0.10% |